Publication

Wilms G, Schofield K, Maddern S, Foley C, Shaw Y, Smith B, Basantes LE, Schwandt K, Babendreyer A, Chavez T, et al. 2024. Discovery and Functional Characterization of a Potent, Selective, and Metabolically Stable PROTAC of the Protein Kinases DYRK1A and DYRK1B. Journal of Medicinal Chemistry. 67(19):17259–17289. doi:10.1021/acs.jmedchem.4c01130.

Kadama-Makanga P, Semeere A, Laker-Oketta M, Mubiru M, Lukande R, Huchko M, Freeman E, Kulkarni N, Martin J, Kang D, et al. 2024. Usability of a smartphone-compatible, confocal micro-endoscope for cervical cancer screening in resource-limited settings. BMC Women’s Health. 24(1). doi:10.1186/s12905-024-03323-5.

Coursey K, Muralidhar K, Srinivas V, Jaykrishna P, Begum F, Ningaiah N, Lee S-J, Madhivanan P. 2024. Acceptability of HPV vaccination for cervical cancer prevention amongst emerging adult women in rural Mysore, India: a mixed-methods study. BMC Public Health. 24(1). doi:10.1186/s12889-024-19485-8.

Morrill KE, Wightman P, Cruz A, Batai K, Block GD, Hsu C-H, Garcia DO. 2024. Disparities in hepatocellular carcinoma incidence among Hispanic and non-Hispanic adults in Arizona: Trends between 2009-2017. Annals of Epidemiology. 96:48–52. doi:10.1016/j.annepidem.2024.05.012.

Gin A, Nguyen P-D, Melzer JE, Li C, Strzelinski H, Liggett SB, Su J. 2024. Label-free, real-time monitoring of membrane binding events at zeptomolar concentrations using frequency-locked optical microresonators. Nature Communications. 15(1). doi:10.1038/s41467-024-51320-x.

Coplen CP, Sonar SA, Nikolich JŽ. 2024. Late-life Attenuation of Cytomegalovirus-mediated CD8 T Cell Memory Inflation: Shrinking of the Cytomegalovirus Latency Niche. The Journal of Immunology. 213(7):965–970. doi:10.4049/jimmunol.2400113.

Galouzis N, Khawam M, Alexander EV, Khreiss MR, Luu C, Mesropyan L, Riall TS, Kwass WK, Dull RO. 2024. Pilot Study to Optimize Goal-directed Hemodynamic Management During Pancreatectomy. Journal of Surgical Research. 300:173–182.

Ortiz HR, Cruz Flores P, Podgorski J, Ramonett A, Ahmed T, Hempel N, Charest PG, Ellis NA, Langlais PR, Montfort WR, et al. 2024. Extracellular signals induce dynamic ER remodeling through αTAT1-dependent microtubule acetylation. Neoplasia. 53:101003. doi:10.1016/j.neo.2024.101003.

Smith SF, Islam AT, Alimukhamedov S, Weiss ET, Charest PG. 2024. Molecular determinants of Ras-mTORC2 signaling. Journal of Biological Chemistry. 300(7):107423. doi:10.1016/j.jbc.2024.107423.

Laurila KA, Rogers LD, Valencia CI, Lee N, de Heer H, Bea JW, Ingram JC, Gachupin FC. 2024. Advancing Cancer Workforce Capacity for American Indians and Alaska Natives: The Development of a Validated System to Optimize Trainee Participation and Outcome Tracking. International Journal of Environmental Research and Public Health. 21(6):752. doi:10.3390/ijerph21060752.

Evans VJ, Wu X, Tran KK, Tabofunda SK, Ding L, Yin L, Edwards P, Zhang Q-Y, Ding X, Van Winkle LS. 2024. Impact of aging and ergothioneine pre-treatment on naphthalene toxicity in lung. Toxicology Letters. 397:89–102. doi:10.1016/j.toxlet.2024.05.014.

Liang B, Zhao J, Kim Y, Barry-Holson KQ, Bingham DB, Charville GW, Darragh TM, Folkins AK, Howitt BE, Kong CS, et al. 2024. Scattering-Based Light-Sheet Microscopy Imaging of Human Papillomavirus–Associated Squamous Lesions of the Anal Canal: A Proof-of-Principle Study. Modern Pathology. 37(6):100493. doi:10.1016/j.modpat.2024.100493.

Tahsin S, Sane NS, Cernyar B, Jiang L, Zohar Y, Lee BR, Miranti CK. 2024. AR loss in prostate cancer stroma mediated by NF-κB and p38-MAPK signaling disrupts stromal morphogen production. Oncogene. 43(27):2092–2103. doi:10.1038/s41388-024-03064-7.

Lott BE, Yeo S, Bekele E, Birhanu F, Hussein R, Muktar S, Mengiste T, Asfaw E, Madhivanan P, Deressa BT. 2024. Breast Cancer Education and Empowerment in Ethiopia: Evaluating Community-Based Cancer Prevention Efforts Using the RE-AIM Framework. Journal of Cancer Education. 39(6):698–705. doi:10.1007/s13187-024-02453-6.

Morenz AM, Reddy A, Hsu A, Le A, Wong ES, Liao JM. 2024. Disparities in telemedicine use among Native Hawaiian and Pacific Islander individuals insured through Medicaid. Health Affairs Scholar. 2(5).

Herbst-Kralovetz MM, Roe D, Chase D, Willmott L, Borst M, Mourad J, Cui H, Laniewski P, Lorentzen G. 2024 Apr. 30. Cervicovaginal metabolome and tumor characteristics for endometrial cancer detection and risk stratification. Clinical Cancer Research. doi:https://doi.org/10.1158/1078-0432.CCR-23-2934.

Ver Hoeve ES, Calhoun E, Hernandez M, High E, Armin JS, Ali-Akbarian L, Frithsen M, Andrews W, Hamann HA. 2024. Evaluating implementation of a community-focused patient navigation intervention at an NCI-designated cancer center using RE-AIM. BMC Health Services Research. 24(1). doi:10.1186/s12913-024-10919-y.

Lee D, Huntoon K, Wang Y, Kang M, Lu Y, Jeong SD, Link TM, Gallup TD, Qie Y, Li X, et al. 2024. Synthetic cationic helical polypeptides for the stimulation of antitumour innate immune pathways in antigen-presenting cells. Nature Biomedical Engineering. 8(5):593–610.

Plank M, Carmiol N, Mitri B, Lipinski AA, Langlais PR, Capaldi AP. 2024. Systems level analysis of time and stimuli specific signaling through PKA. Kellogg D, editor. Molecular Biology of the Cell. 35(4). doi:10.1091/mbc.e23-02-0066.

Jose E, March-Steinman W, Wilson BA, Shanks L, Parkinson C, Alvarado-Cruz I, Sweasy JB, Paek AL. 2024. Temporal coordination of the transcription factor response to H2O2 stress. Nature Communications. 15(1). doi:10.1038/s41467-024-47837-w.

Fairman CM, Kava CM, Beima-Sofie K, Sakhuja M, Masud M, Dias E, Sheng J, Gorzelitz J, Morshed A, Green BB, et al. 2024 Mar. Addressing differences in cancer: a framework for synergistic programming in cancer prevention and control. doi:10.21203/rs.3.rs-4046415/v1.

Mahmud M, Munjal A, Savani M, Win H, Rozell U, Arshad J. 2024. Biomarker Testing and Role of Tyrosine Kinase Inhibitors and Immunotherapy for Esophageal Squamous Cell Carcinoma. Foregut: The Journal of the American Foregut Society. 4(4):467–474. doi:10.1177/26345161241238748.

Wang Z, Li W, Jiang Y, Park J, Gonzalez KM, Wu X, Zhang Q-Y, Lu J. 2024. Cholesterol-modified sphingomyelin chimeric lipid bilayer for improved therapeutic delivery. Nature Communications. 15(1). doi:10.1038/s41467-024-46331-7.

Lou E, Xiu J, Baca Y, Saeed A, Prakash A, Gholami S, Subramanian S, Starr TK, Fontana E, Pandey R, et al. 2024. Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancers. Molecular Therapy: Oncology. 32(1):200786.

Arshad J, Rao A, Repp ML, Rao R, Wu C, Merchant JL. 2024. Myeloid-Derived Suppressor Cells: Therapeutic Target for Gastrointestinal Cancers. International Journal of Molecular Sciences. 25(5):2985. doi:10.3390/ijms25052985.